Polycyclo Ring System Having The Five-membered Hetero Ring As One Of The Cyclos Patents (Class 548/416)
  • Patent number: 9951226
    Abstract: The present invention relates to a compound based on cyanine scaffold for diagnosing sepsis by selectively detecting glutathione. The compound based on cyanine scaffold according to the present invention has the advantages of maintaining its structure in intracellular environment and of reacting selectively to glutathione only among many amino acids containing thiol group (R—SH) such as cysteine, homocysteine, and glutathione, to produce changes in absorption or fluorescence spectrum, making the compound useful for the detection of in vivo glutathione in biosamples and also for the diagnosis of sepsis characteristically displaying the changes of glutathione concentration.
    Type: Grant
    Filed: March 20, 2015
    Date of Patent: April 24, 2018
    Assignee: EWHA UNIVERSITY—INDUSTRY COLLABORATION FOUNDATION
    Inventors: Juyoung Yoon, Jun Yin, Gyoungmi Kim, Dabin Kim
  • Patent number: 9127017
    Abstract: There are provided compounds comprising optionally substituted (FORMULA I) fused with one or two optionally substituted (FORMULA II), wherein A and E each independently represent —CH2—, —NH—, —O—, —S—, or —C(?O)— and B represents a bond, —CH2—, —NH—, —O—, —S—, or —C(?O)—, said compound having directly or indirectly attached thereto at least one acyl and/or oxime ester group. Such compounds are useful inter alias as photoinitiators.
    Type: Grant
    Filed: May 24, 2012
    Date of Patent: September 8, 2015
    Assignee: American Dye Source, Inc.
    Inventors: My T. Nguyen, Jean-Philippe Tremblay-Morin, Philippe Gaudreault
  • Publication number: 20150084016
    Abstract: An organic electroluminescent element including a luminescent compound represented by the following formula (in which R1 to R14 each independently represent a hydrogen atom, a deuterium atom, an alkyl group, an aryl group, a heteroaryl group, a fluorine atom, a cyano group, an amino group, an alkoxy group, an aryloxy group, a thio group, or a silyl group, and 8 to 13 groups out of R1 to R14 each represent a hydrogen atom or a deuterium atom.) in a light emitting layer has high durability and excellent chromaticity.
    Type: Application
    Filed: October 5, 2012
    Publication date: March 26, 2015
    Applicant: UDC IRELAND LIMITED
    Inventors: Toru Watanabe, Yuki Hirai, Tianhua Ouyang, Koji Takaku, Wataru Sotoyama, Tetsu Kitamura, Yasunori Yonekuta
  • Patent number: 8906953
    Abstract: The present invention relates to the use of a compound of formula 1, a stereoisomer or a tautomer thereof, or a pharmaceutically acceptable salt or a pharmaceutically acceptable solvate thereof, for the treatment of an inflammatory disorder. The invention further relates to a pharmaceutical composition comprising a compound of formula 1 and at least one pharmaceutically acceptable carrier, for use in the treatment of an inflammatory disorder. The invention also relates to a method for the treatment of an inflammatory disorder by administering a therapeutically effective amount of the compound of formula 1 to a subject in need thereof.
    Type: Grant
    Filed: February 26, 2010
    Date of Patent: December 9, 2014
    Assignee: Piramal Enterprises Limited
    Inventors: Kalpana Sanjay Joshi, Sapna Hasit Parikh
  • Publication number: 20140353640
    Abstract: A heterocyclic compound wherein three five-membered rings are fused to one benzene ring and a saturated or unsaturated ring is fused to each five-membered ring. An organic electroluminescence device includes one or more organic thin film layers between an anode and a cathode. The one or more organic thin film layers include a light emitting layer. At least one layer of the one or more organic thin film layers includes the heterocyclic compound.
    Type: Application
    Filed: May 29, 2014
    Publication date: December 4, 2014
    Applicant: Idemitsu Kosan Co., Ltd.
    Inventors: Tasuku HAKETA, Masahiro KAWAMURA, Kazuki NISHIMURA, Yumiko MIZUKI, Hirokatsu ITO, Tomoharu HAYAMA
  • Patent number: 8901157
    Abstract: The present invention discloses compositions and a method of improving the pharmacokinetics of pharmaceutical agents (or pharmaceutically acceptable salts, esters, and prodrugs thereof) which are metabolized by cytochrome P450 monoxygenase comprising coadministering ritonavir or a pharmaceutically acceptable salt, ester, and prodrug thereof.
    Type: Grant
    Filed: December 2, 2010
    Date of Patent: December 2, 2014
    Assignee: AbbVie Inc.
    Inventors: Dale J. Kempf, Kennan C. Marsh
  • Publication number: 20140319495
    Abstract: An organic compound has a dibenzo[8,9:10,11]tetrapheno[5,6-b]carbazole skeleton as a basic skeleton. An organic light-emitting device includes an anode, a cathode, and an organic compound layer including the organic compound. A display apparatus includes a plurality of pixels, and each of the pixels includes the organic light-emitting device and a transistor. An image display system includes an input section and a display section including the display apparatus. A lighting apparatus includes the organic light-emitting device and an inverter circuit. An electrophotographic image-forming apparatus includes a light source including a plurality of the organic light-emitting devices and a photosensitive member.
    Type: Application
    Filed: April 28, 2014
    Publication date: October 30, 2014
    Applicant: CANON KABUSHIKI KAISHA
    Inventors: Masumi Itabashi, Hirokazu Miyashita, Ryuji Ishii, Masanori Muratsubaki, Jun Kamatani
  • Publication number: 20140319507
    Abstract: This application relates, in part, to an organic electroluminescent element including a substrate, a pair of electrodes including an anode and a cathode, disposed on the substrate, and at least one organic layer including a light emitting layer, disposed between the electrodes, in which at least one layer of the organic layer(s) contains a compound represented by the following formula (1). The organic electroluminescent element has low driving voltage and excellent durability. wherein X1 to X11 represent CR0 or N, and R0 represents a hydrogen atom or a substituent. Adjacent two of X1 to X11 each independently represent at least CR0, R0s of the adjacent two CR0s are bonded to each other to form a ring, and only one R0 of the adjacent two CR0s represents an aryl group or a heteroaryl group.
    Type: Application
    Filed: November 21, 2012
    Publication date: October 30, 2014
    Applicant: UDC Ireland Limited
    Inventors: Yosuke Yamamoto, Kousuke Watanabe, Yuichiro Itai
  • Publication number: 20140291654
    Abstract: A heterocyclic compound represented by Formula 1 below and an organic light-emitting device including the heterocyclic compound: wherein R1 to R12 are defined as in the specification.
    Type: Application
    Filed: June 12, 2014
    Publication date: October 2, 2014
    Inventors: Young-Kook Kim, Seok-Hwan Hwang, Yoon-Hyun Kwak, Sun-Young Lee, Hye-Jin Jung, Jin-O Lim, Jong-Hyuk Lee
  • Publication number: 20140231754
    Abstract: The present invention discloses a novel ditriphenylene derivative is represented by the following formula (I), the organic EL device employing the ditriphenylene derivative as host material or dopant material of emitting layer can lower driving voltage, prolong half-life time and increase the efficiency. Wherein m, n represent an integer of 0 to 10. X is a divalent bridge selected from the atom or group consisting from O, S, C(R3)(R4), NR5, Si(R6)(R7). Ar1, Ar2, R1 to R7 are substituents and the same definition as described in the present invention.
    Type: Application
    Filed: February 20, 2013
    Publication date: August 21, 2014
    Inventor: Feng-Wen Yen
  • Publication number: 20140200350
    Abstract: There are provided compounds comprising optionally substituted (FORMULA I) fused with one or two optionally substituted (FORMULA II), wherein A and E each independently represent —CH2—, —NH—, —O—, —S—, or —C(?O)— and B represents a bond, —CH2—, —NH—, —O—, —S—, or —C(?O)—, said compound having directly or indirectly attached thereto at least one acyl and/or oxime ester group. Such compounds are useful inter alias as photoinitiators.
    Type: Application
    Filed: May 24, 2012
    Publication date: July 17, 2014
    Applicant: AMERICAN DYE SOURCE, INC.
    Inventors: My T. Nguyen, Jean-Philippe Tremblay-Morin, Philippe Gaudreault
  • Publication number: 20140183489
    Abstract: The present invention provides a novel compound that is capable of largely improving a life span, efficiency, electrochemical stability and thermal stability of an organic light emitting device, and an organic light emitting device in which the compound is included in an organic compound layer.
    Type: Application
    Filed: June 20, 2012
    Publication date: July 3, 2014
    Applicant: LG CHEM, LTD.
    Inventors: Sung Kil Hong, Yun Hwan Kim, Jungoh Huh, Seongmi Cho, Seong So Kim, Yongbum Cha
  • Publication number: 20140166988
    Abstract: The present invention discloses a novel organic compound is represented by the following formula(I), the organic EL device employing the organic compound as host material or dopant material of emitting layer and/or as electron transporting material can lower driving voltage, prolong half-lifetime and increase the efficiency. wherein m represent an integer of 0 to 10, n represent an integer of 0 to 2. X is a divalent bridge selected from the atom or group consisting from O, S, C(R5)2, N(R5), Si(R5)2. Ar, R1 to R4 are substituents and the same definition as described in the present invention.
    Type: Application
    Filed: December 17, 2012
    Publication date: June 19, 2014
    Applicant: LUMINESCENCE TECHNOLOGY CORPORATION
    Inventors: Feng-Wen Yen, Chen-Hao Chang
  • Patent number: 8742133
    Abstract: The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.
    Type: Grant
    Filed: August 13, 2008
    Date of Patent: June 3, 2014
    Assignee: Synta Pharmaceuticals Corp.
    Inventors: Weiwen Ying, Lijun Sun, Keizo Koya, Dinesh U. Chimmanamada, Shijie Zhang, Teresa Kowalcyzk-Przewloka, Hao Li
  • Publication number: 20140138661
    Abstract: The present invention relates to crosslinkable compounds, to the crosslinked compounds obtained from these compounds, and to processes for the preparation thereof. The invention is furthermore directed to the use of these compounds in electronic devices and to the corresponding electronic devices themselves.
    Type: Application
    Filed: June 29, 2012
    Publication date: May 22, 2014
    Applicant: MERCK PATENT GmbH
    Inventors: Aurélie Ludemann, Alice Julliart, Anna Hayer, Anja Gerhard, Dominik Joosten, Holger Heil, Fabrice Eckes
  • Publication number: 20140124762
    Abstract: Embodiments described herein relate to compositions including iptycene-based structures and extended iptycene structures. In some embodiments, the compositions may be useful in organic light-emitting diodes (OLEDs), organic photovoltaics, and other devices.
    Type: Application
    Filed: October 30, 2013
    Publication date: May 8, 2014
    Applicant: Massachusetts Institute of Technology
    Inventors: Stephen L. Buchwald, Timothy M. Swager, Georgiy Teverovskiy, Mingjuan Su
  • Patent number: 8716493
    Abstract: The present invention is directed to novel multicyclic molecules that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of PARP, VEGFR2, and MLK3 enzymes, including, for example, neurodegenerative diseases, inflammation, ischemia, and cancer.
    Type: Grant
    Filed: November 18, 2010
    Date of Patent: May 6, 2014
    Assignee: Cephalon, Inc.
    Inventors: Sankar Chatterjee, Reddeppa reddy Dandu, James L. Diebold, Derek D. Dunn, Robert L. Hudkins, Gregory J. Wells, Allison L. Zulli
  • Publication number: 20140117326
    Abstract: A heterocyclic compound represented by Formula 1 below, and an organic light-emitting device including the heterocyclic compound:
    Type: Application
    Filed: July 11, 2013
    Publication date: May 1, 2014
    Inventors: Sun-Young LEE, Yoon-Hyun KWAK, Bum-Woo PARK, Jong-Won CHOI, Wha-IL CHOI, So-Yeon KIM, Ji-Youn LEE
  • Publication number: 20140091298
    Abstract: The present invention provides a novel compound that is capable of largely improving a life span, efficiency, electrochemical stability and thermal stability of an organic light emitting device, and an organic light emitting device in which the compound is included in an organic compound layer.
    Type: Application
    Filed: December 10, 2013
    Publication date: April 3, 2014
    Applicant: LG CHEM, LTD.
    Inventors: Sung Kil HONG, Yun Hwan KIM, Jungoh HUH, Seongmi CHO, Seong So KIM, Yongbum CHA
  • Patent number: 8653286
    Abstract: Methods for forming maleimide functionalized polymers are provided. In one such embodiment, a maleimide functionalized polymer is prepared in a method that includes a step of carrying out a reverse Diels-Alder reaction. Intermediates useful in the methods, as well as methods for preparing the intermediates, are also provided. Also provided are polymeric reagents, methods of using polymeric reagents, compounds and conjugates.
    Type: Grant
    Filed: August 7, 2012
    Date of Patent: February 18, 2014
    Assignee: Nektar Therapeutics
    Inventors: Samuel P. McManus, Antoni Kozlowski, Tracy L. Hutchison, Brian Bray, Xiaoming Shen
  • Publication number: 20140034879
    Abstract: The present invention relates to a compound of a formula (I) or (II), to the use of this compound in an electronic device, and to an electronic device comprising one or more compounds of the formula (I) or (II). The invention furthermore relates to the preparation of the compound of the formula (I) or (II) and to a formulation comprising one or more compounds of the formula (I) or (II).
    Type: Application
    Filed: March 15, 2012
    Publication date: February 6, 2014
    Applicant: Merck Patent GmbH
    Inventors: Christof Pflumm, Irina Martynova, Teresa Mujica-Fernaud
  • Publication number: 20140034913
    Abstract: A condensation compound is represented by Formula 1, 2, or 3 where R1 to R24 and A to F are further defined in the detailed description.
    Type: Application
    Filed: January 8, 2013
    Publication date: February 6, 2014
    Inventors: So-Yeon KIM, Yoon-Hyun KWAK, Bum-Woo PARK, Jong-Won CHOI, Wha-II CHOI, Sun-Young LEE, Ji-Youn LEE, Jin-Young YUN
  • Publication number: 20140027755
    Abstract: The present invention relates to an electronic device comprising one or more compounds of a formula (I) or (II). Furthermore, the invention encompasses the use of a compound of the formula (I) or (II) in an electronic device, and the provision of certain compounds of the formula (I) or (II).
    Type: Application
    Filed: March 15, 2012
    Publication date: January 30, 2014
    Applicant: Merck Patent GmbH Patents & Scientific Information
    Inventors: Teresa Mujica-Fernaud, Christof Pflumm, Irina Martynova
  • Patent number: 8609867
    Abstract: A substituted indolocarbazole comprising at least one optionally substituted thienyl.
    Type: Grant
    Filed: February 6, 2012
    Date of Patent: December 17, 2013
    Assignee: Xerox Corporation
    Inventors: Yiliang Wu, Beng S. Ong, Yu Qi, Yuning Li
  • Publication number: 20130320269
    Abstract: This invention relates to a novel process for preparing compounds comprising moieties of formula (I) and polymers comprising monomers of formula (II) or (III) as defined herein. The present invention also provides novel compounds of formula (I) and novel polymers comprising monomers of formula (II) or (III) as defined herein, as well as to the use of such compounds and polymers in organic semiconductor applications.
    Type: Application
    Filed: December 8, 2011
    Publication date: December 5, 2013
    Applicant: THE UNIVERSITY OF MANCHESTER
    Inventors: Nicolas Cocherel, Benjamin John Lidster, Michael L. Turner
  • Publication number: 20130310572
    Abstract: The present invention provides a free radical polymerizable liquid crystal alignment agent having superior coating ability, a manufacturing method, which comprises the process of coating the liquid crystal alignment agent onto a substrate, and processing the liquid crystal alignment agent with dehydration/ring-closure reaction and free radical polymerization, enables obtaining a liquid crystal alignment film with superior reliability, superior voltage holding ratio and easy control of pretilt angle, and enables the manufacture of a liquid crystal display element provided with a liquid crystal alignment film. The free radical polymerizable liquid crystal alignment agent comprises a molecular compound containing at least 2 polymerizable maleamic acid groups and an organic solvent.
    Type: Application
    Filed: July 29, 2013
    Publication date: November 21, 2013
    Applicant: Chi Mei Corporation
    Inventor: Huai-Pin Hsueh
  • Publication number: 20130306917
    Abstract: The invention relates to a photovoltaic coating containing a mixture of organic N-type (acceptor) and P-type (donor) semiconductor compounds, which makes it possible, when selecting the donor/acceptor pair, to modulate the semiconductor properties of the photovoltaic coating so as to enable the use thereof within a photovoltaic device, wherein one of the organic semiconductors includes a quinone core.
    Type: Application
    Filed: October 21, 2011
    Publication date: November 21, 2013
    Applicant: RHODIA OPERATIONS
    Inventors: Floryan Decampo, Gerard Mignani, Bertrand Pavageau
  • Publication number: 20130274256
    Abstract: Certain multi-cyclic compounds and compositions thereof are useful for reducing or inhibiting the growth of bacterial biofilms and for controlling bacterial biofilm infections. Such compounds and compositions are also useful in methods for reducing or inhibiting the growth of biofilms and for controlling bacterial biofilm infections involving biofilms.
    Type: Application
    Filed: October 11, 2012
    Publication date: October 17, 2013
    Applicant: SEQUOIA SCIENCES, INC.
    Inventor: Sequoia Sciences, Inc.
  • Patent number: 8501958
    Abstract: A compound for absorbing sunlight and converting the sunlight into electrical energy, which is formed by coupling a fullerene with at least one or more triarylamine derivatives. The fullerene is selected from among those having carbon numbers C60, C70, C78, C82 and C84, and the triarylamine derivatives are coupled with at least one or more aliphatic or aromatic hydrocarbons and are also coupled with a dopant. A method of manufacturing the compound includes steps of synthesizing a fullerene derivative, synthesizing fullerene-triarylamine, wherein a fullerene-triarylamine adduct is prepared by coupling the fullerene derivative with a triarylamine derivative, preparing an adduct solution by dissolving the fullerene-triarylamine adduct in an organic solvent, and conducting a doping reaction by adding an acid dropwise slowly to the adduct solution.
    Type: Grant
    Filed: January 9, 2009
    Date of Patent: August 6, 2013
    Assignee: Kyungpook National University Industry- Academic Cooperation Foundation
    Inventors: Youngkyoo Kim, Minjung Shin, Inhyuk Lee, Hwajeong Kim
  • Patent number: 8455866
    Abstract: A heterocyclic compound of formula 1 and an organic light-emitting device including an organic layer containing the heterocyclic compound. The heterocyclic compound of Formula 1 may be suitable as a material for an emission layer, an electron transport layer or an electron injection layer of an organic light-emitting device. Due to the inclusion of the heterocylic group in its molecular structure, the heterocyclic compound of Formula 1 may have a high glass transition temperature (Tg) or a high melting point, and may prevent crystallization. An organic light-emitting device manufactured using the heterocyclic compound of Formula 1, which has a symmetrical structure in which a chrysene group and an indole group are fused, has excellent durability when stored or operated.
    Type: Grant
    Filed: March 31, 2011
    Date of Patent: June 4, 2013
    Assignee: Samsung Display Co., Ltd.
    Inventors: Hye-Jin Jung, Seok-Hwan Hwang, Young-Kook Kim, Yoon-Hyun Kwak, Jin-O Lim, Jong-Hyuk Lee
  • Patent number: 8455867
    Abstract: A heterocyclic compound represented by a general Formula 1 and an organic light-emitting device including the heterocyclic compound. In some embodiments the heterocyclic compound of Formula 1 may be used as a light-emitting material, a hole transporting material, or an electron transporting material. The heterocyclic compound of Formula 1 having a heterocyclic group in the molecules thereof has a high glass transition temperature (Tg) or a high melting point due to the inclusion of the heterocyclic group. Thus, the heterocyclic compound has high heat resistance against Joule's heat generated in an organic layer, between organic layers, or between an organic layer and a metal electrode when light emission occurs, and has high durability in high-temperature environments. An organic light-emitting device manufactured using the heterocyclic compound of Formula 1 has high durability when stored or operated.
    Type: Grant
    Filed: April 1, 2011
    Date of Patent: June 4, 2013
    Assignee: Samsung Display Co., Ltd.
    Inventors: Young-Kook Kim, Seok-Hwan Hwang, Hye-Jin Jung, Jin-O Lim, Sang-Hyun Han, Yoon-Hyun Kwak, Sun-Young Lee, Jong-Hyuk Lee, Sung-Chul Kim
  • Patent number: 8440841
    Abstract: The present invention relates to novel 5-pyrrolidinylsulfonyl isatin derivatives, non-peptidyl Caspase binding Radioligands (CbRs) and CbR-transporter conjugates derived from said isatin derivatives, diagnostic compositions comprising said compounds of the invention and their use for non-invasive diagnostic imaging.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: May 14, 2013
    Assignee: Universitätsklinikum Münster
    Inventors: Klaus Kopka, Bodo Levkau, Michael Schäfers
  • Patent number: 8431602
    Abstract: Novel heterocyclic compounds of the formula I in which R1, R2, R2?, R2?, R3, R4, R5, R6, R7 and R8 have the meanings indicated in Claim 1, are activators of glucokinase and can be used for the prevention and/or treatment of Diabetes Typ 1 and 2, obesity, neuropathy and/or nephropathy.
    Type: Grant
    Filed: December 23, 2008
    Date of Patent: April 30, 2013
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Stefan Bender, Lars Thore Burgdorf, Ulrich Emde, Norbert Beier, Johannes Gleitz, Christine Charon
  • Patent number: 8420830
    Abstract: The present invention relates generally to novel macrocycles of Formula (I): or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein the variables A, B, C, D, L, M, W, Z1, Z2, Z3, Z4, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: April 16, 2013
    Assignee: Bristol-Myers Squibb Company
    Inventors: Nicholas Ronald Wurtz, Eldon Scott Priestley, Daniel L. Cheney, Peter W. Glunz, Xiaojun Zhang, Brandon Parkhurst, Vladimir Ladziata, Luciano Mueller
  • Publication number: 20130087768
    Abstract: A heterocyclic compound represented by Formula 1 below, an organic light-emitting diode including the same, and a flat panel display device including the organic light-emitting diode: where X is *—Ar1 or wherein Ar1, Ar2, R1, R2, R3, R4, Y1, Y2, Y3, Y4, a, b, c, and d are as defined in the specification.
    Type: Application
    Filed: February 17, 2012
    Publication date: April 11, 2013
    Applicant: SAMSUNG MOBILE DISPLAY CO., LTD.
    Inventors: Young-Kook Kim, Seok-Hwan Hwang, Hye-Jin Jung, Jin-O Lim, Sang-Hyun Han, Se-Jin Cho, Jong-Hyuk Lee
  • Patent number: 8405074
    Abstract: A heterocyclic compound represented by a general Formula 1 and an organic light-emitting device including the heterocyclic compound. In some embodiments the heterocyclic compound of Formula 1 may be used as a light-emitting material, a hole transporting material, or an electron transporting material. The heterocyclic compound of Formula 1 having a heterocyclic group in the molecules thereof has a high glass transition temperature (Tg) or a high melting point due to the inclusion of the heterocyclic group. Thus, the heterocyclic compound has high heat resistance against Joule's heat generated in an organic layer, between organic layers, or between an organic layer and a metal electrode when light emission occurs, and has high durability in high-temperature environments. An organic light-emitting device manufactured using the heterocyclic compound of Formula 1 has high durability when stored or operated.
    Type: Grant
    Filed: April 1, 2011
    Date of Patent: March 26, 2013
    Assignee: Samsung Display Co., Ltd.
    Inventors: Young-Kook Kim, Seok-Hwan Hwang, Hye-Jin Jung, Jin-O Lim, Sang-Hyun Han, Yoon-Hyun Kwak, Sun-Young Lee, Jong-Hyuk Lee, Sung-Chul Kim
  • Publication number: 20130048975
    Abstract: The present invention relates to a material for an organic electroluminescent device, including a phenanthrocarbazole-based compound having a specific structure, and an organic electroluminescent device including the same. More specifically, the phenanthrocarbazole-based compound is applied as a material for a phosphorescent and fluorescent organic electroluminescent device, thereby providing an organic light emitting device with improved light emitting efficiency, luminance, thermal stability, driving voltage, lifetime and the like.
    Type: Application
    Filed: May 6, 2011
    Publication date: February 28, 2013
    Applicant: Doosan Corporation
    Inventors: Jin-Seok Hong, Eun Jung Lee, Shin Han Kim, Kyoung-Soo Kim
  • Publication number: 20120322808
    Abstract: The present invention relates to novel ?4?2 neuronal nicotinic acetylcholine receptor ligand compounds of the formula (I), and their derivatives, stereoisomers, pharmaceutically acceptable salts and compositions containing them. The present invention relates to novel ?4?2 neuronal nicotinic acetylcholine receptor ligand compounds of the formula (I), and their derivatives, stereoisomers, pharmaceutically acceptable salts and compositions containing them.
    Type: Application
    Filed: May 3, 2010
    Publication date: December 20, 2012
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna Nirogi, Abdul Rasheed Mohammed, Kana Ram Kumawat, Ishtiyaque Ahmad, Pradeep Jayarajan, Anil Karbhari Shinde, Nagaraj Vishwottam Kandikere, Koteshwara Mudigonda, Venkateswarlu Jasti
  • Publication number: 20120296097
    Abstract: A preparation method of original dye of Vat Brown R comprises the following steps: a. after acylation of 1,5-diaminoanthraquinone, 1-amino-5-benzamidoanthraquinone was prepared by acidic hydrolysis; b. 1-benzamido-4-bromoanthraquinone was obtained from 1-aminoanthraquinone by acylation and bromination; c. a condensate of Vat Brown R was obtained by condensation reaction of 1-amino-5-benzamidoanthraquinone and 1-benzamido-4-bromoanthraquinone; d. the original dye of Vat Brown R was obtained from the condensate of Vat Brown R by ring closing reaction and oxidation reaction. The method omits one oxidation step, economizes significant amount of oxidizing agent, and reduces significant amount of waste water, so it is very beneficial to environment protection; and the method also exhibited the advantages of highly increasing product yield and reducing the costs of raw materials to an extent of more than 30%.
    Type: Application
    Filed: December 17, 2009
    Publication date: November 22, 2012
    Inventors: Dezhi Xiang, Dejun Yan, Chongli Xu, Ying Shao, Ping Fu, Hongwei Wang, Shunli Su, Jiarong Wei, Changjing Wang, Qinghe Shang, Jian Li, Yan Dou, Hui Du, Jinchao Miao, Hui Liu, Yongwei Li, Lianfeng Li, Yongmei Xu, Mei Zhang, Xianxu Zhang
  • Publication number: 20120273770
    Abstract: A compound for an organic thin film transistor represented by the following formula (1):
    Type: Application
    Filed: December 13, 2010
    Publication date: November 1, 2012
    Inventors: Misa Sunagawa, Masatoshi Saito, Hiroaki Nakamura, Hirofumi Kondo, Naoki Kurihara, Masahiro Kawamura
  • Patent number: 8222425
    Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.
    Type: Grant
    Filed: July 19, 2011
    Date of Patent: July 17, 2012
    Assignee: Novartis AG
    Inventors: Shawn D. Britt, Lech Andrzej Ciszewski, Jiping Fu, Subramanian Karur, Yugang Liu, Peichao Lu, David Thomas Parker, Mahavir Prashad, Prakash Raman, Pascal Rigollier, Mohindra Seepersaud, Aregahegn Yifru, Rui Zheng
  • Patent number: 8217041
    Abstract: The present invention makes reference to new indene derivatives with general formula (I), as well as to their preparation procedures, their application as medicament and the pharmaceutical compositions containing them. The new compounds of formula (I) show affinity for 5-HT6 receptors and are, therefore, effective for treating diseases mediated by these receptors.
    Type: Grant
    Filed: November 7, 2006
    Date of Patent: July 10, 2012
    Assignee: Laboratories del Sr. Esteve, S.A.
    Inventors: Maria de las Ermitas Alcalde-Pais, Jordi Frigola-Constansa, Joerg Holenz, Ramon Merce-Vidal, Maria de les Neus Mesquida-Estevez, Sara Lopez-Perez
  • Publication number: 20120157689
    Abstract: A substituted indolocarbazole comprising at least one optionally substituted thienyl.
    Type: Application
    Filed: February 6, 2012
    Publication date: June 21, 2012
    Applicant: Xerox Corporation
    Inventors: Yiliang Wu, Beng S. Ong, Yu Qi, Yuning Li
  • Patent number: 8193228
    Abstract: Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.
    Type: Grant
    Filed: October 16, 2007
    Date of Patent: June 5, 2012
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: David Chen, Christopher L. Franklin, Peter R. Guzzo, Linus S. Lin, Michael M. C. Lo, Ravi P. Nargund, Iyassu K. Sebhat
  • Patent number: 8183275
    Abstract: Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.
    Type: Grant
    Filed: October 16, 2007
    Date of Patent: May 22, 2012
    Assignees: Merck Sharp & Dohme Corp., Albany Molecular Research, Inc.
    Inventors: Peter H. Dobbelaar, Christopher L. Franklin, Allan Goodman, Cheng Guo, Peter R. Guzzo, Mark Hadden, Shuwen He, Alan J. Henderson, Tianying Jian, Linus S. Lin, Jian Liu, Ravi P. Nargund, Megan Ruenz, Bruce J. Sargent, Iyassu K. Sebhat, Larry Yet
  • Publication number: 20120097929
    Abstract: A heterocyclic compound represented by Formula 1 below and an organic light-emitting device including the heterocyclic compound: wherein R1 to R12 are defined as in the specification.
    Type: Application
    Filed: August 16, 2011
    Publication date: April 26, 2012
    Applicant: Samsung Mobile Display CO., LTD.
    Inventors: Young-Kook Kim, Seok-Hwan Hwang, Yoon-Hyun Kwak, Sun-Young Lee, Hye-Jin Jung, Jin-O Lim, Jong-Hyuk Lee
  • Publication number: 20120068170
    Abstract: The present invention describes indenocarbazole derivatives having electron- and hole-transporting properties, in particular for use in the emission and/or charge-transport layer of electroluminescent devices or as matrix material. The invention furthermore relates to a process for the preparation of the compounds according to the invention and to electronic devices comprising same.
    Type: Application
    Filed: May 3, 2010
    Publication date: March 22, 2012
    Applicant: MERCK PATENT GmbH
    Inventors: Christof Pflumm, Arne Buesing, Amir Hossain Parham, Teresa Mujica-Fernaud, Holger Heil, Philipp Stoessel
  • Patent number: 8119375
    Abstract: An improved method for preparing ramipril is disclosed, and also an intermediate for use in the method.
    Type: Grant
    Filed: June 19, 2008
    Date of Patent: February 21, 2012
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Holger Berk, Frank Zocher, Hans-Wolfram Flemming, Rainer Gauler, Rudolf Lehnert, Wolfgang Laux
  • Patent number: 8110690
    Abstract: A substituted indolocarbazole comprising at least one optionally substituted thienyl.
    Type: Grant
    Filed: October 16, 2008
    Date of Patent: February 7, 2012
    Assignee: Xerox Corporation
    Inventors: Yiliang Wu, Beng S Ong, Yu Qi, Yuning Li
  • Publication number: 20110253944
    Abstract: The present invention relates to a novel polycyclic aromatic organic semiconductor compound having a polycyclic aromatic core, a method for preparing the same, and electronic, optical or electro-optical devices such as an organic semiconductor composition, organic semiconductor thin film, organic field effect transistor and solar cell containing the compound. The novel organic semiconductor compound according to the present invention has high crystallinity and control capability, and facilitates control of doping conditions in the manufacture of organic semiconductor element so that it can be used for diverse applications. The compound can be mass-produced at low cost and has high solubility in organic solvents so that a liquid phase process can be applied to the manufacture of semiconductor elements and the like, thus enabling the mass-production of semiconductor elements and solar cells at low cost.
    Type: Application
    Filed: December 23, 2009
    Publication date: October 20, 2011
    Applicant: LUMINANO CO., LTD.
    Inventors: Sung Hwan Han, Cheon Gyu Cho